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This study reports the design and evaluation of a new synthetic receptor sensor based on the amalga-
mation of biomolecular recognition elements and molecular imprinting to overcome some of the chal-
lenges faced by conventional protein imprinting. A thiolated DNA aptamer with established afﬁnity for
prostate speciﬁc antigen (PSA) was complexed with PSA prior to being immobilised on the surface of a
gold electrode. Controlled electropolymerisation of dopamine around the complex served to both entrap
the complex, holding the aptamer in, or near to, it’s binding conformation, and to localise the PSA
binding sites at the sensor surface. Following removal of PSA, it was proposed that the molecularly
imprinted polymer (MIP) cavity would act synergistically with the embedded aptamer to form a hybrid
receptor (apta–MIP), displaying recognition properties superior to that of aptamer alone. Electrochemical
impedance spectroscopy (EIS) was used to evaluate subsequent rebinding of PSA to the apta–MIP surface.
The apta–MIP sensor showed high sensitivity with a linear response from 100 pg/ml to 100 ng/ml of PSA
and a limit of detection of 1 pg/ml, which was three-fold higher than aptamer alone sensor for PSA.
Furthermore, the sensor demonstrated low cross-reactivity with a homologous protein (human Kallik-
rein 2) and low response to human serum albumin (HSA), suggesting possible resilience to the non-
speciﬁc binding of serum proteins.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Whilst antibodies remain the molecular recognition workhorse
of choice for many laboratory assays and bio-sensing devices, their
use can impose limitations on both technology adoption and re-
sulting applications. Issues such as cost, availability, stability, ro-
bustness and engineerability all must be taken into consideration
in assay or device design. One long-championed ‘alternative’ to
antibodies has been molecular imprinting, yet despite its many
supporters the approach has had little impact as a viable bioana-
lytical tool to date. At the heart of this rather disappointing picture
is a critical limitation, that conventional non-covalent molecular
imprinting is fundamentally unsuitable as a mean for preparing
antibody-alternatives for use in water; the most important solventr B.V. This is an open access articl
ristol.ac.uk (R.L. Harniman),
.uk (C.J. Allender),
script.with regards to commercially relevant applications of molecular
recognition. For proteins in particular, where molecular size brings
issue of permanent entrapment and kinetic limitations (Turner
et al., 2006), molecular imprinting, despite a huge amount of at-
tention by researchers, has been unable to ﬁnd any foothold in
what is a huge commercial market.
One approach that has shown promise in the area of macro-
molecular imprinting is the integration of biomolecules, with in-
herent afﬁnity for a particular protein target, into a MIP polymer
scaffold, giving rise to a so-called hybrid-MIP system. The hy-
pothesis underpinning the creation of such hybrid systems is that
the ‘templating’ effects will give rise to afﬁnities and/or selectivity
above and beyond that demonstrated by the biomolecule alone.
The hybrid-MIP strategy was ﬁrst proposed for the detection of
lipopolysaccharide (LPS) using the cyclic peptide polymyxin (Bo-
wen, 2011) and has also been reported for concanavalin A detec-
tion using mannose (Dechtrirat et al., 2014).
Another type of bioreceptor that has been employed in hybrid-
MIP approaches is the DNA aptamer (Bai and Spivak, 2014; Poma
et al., 2015). DNA aptamers are short, stable oligonucleotide se-
quences possessing high afﬁnity and speciﬁcity for particulare under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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their own right, been extensively used as alternatives to antibodies
in biosensing applications (‘Aptasensors’) (Rodriguez et al., 2005;
Maehashi et al., 2007; Jolly et al., 2015a). Despite their inherent
stability DNA aptamers are still subject to nuclease degradation
(Keum and Bermudez, 2009) and an additional beneﬁt of their
incorporation within hybrid polymer systems has been shown to
be an increase in stability (Poma et al., 2015).
This study aims to develop a hybrid-MIP receptor for use in an
electrochemical sensor targeting the quantitative analysis of
prostate speciﬁc antigen (PSA). PSA is a 30–33 KDa serine protease
secreted by the prostate gland, the levels of which are elevated in
men with prostate cancer (PCa) (Heidenreich et al., 2014a). Despite
well-documented limitations (Hayes and Barry, 2014), PSA re-
mains most commonly used biomarker for PCa screening, mon-
itoring the effectiveness of treatment and assessing likelihood of
remission post treatment (Hayes and Barry, 2014; Heidenreich
et al., 2014b).
Unlike previous studies, this work does not rely on the che-
mical modiﬁcation of the biorecognition motif in order to make it
‘polymerisable’ (Poma et al., 2015). In the current study, a pre-
formed ‘thiolated DNA aptamer–PSA’ complex is immobilised onto
the surface of a clean gold electrode. By surface immobilising the
complex prior to polymerisation, the order and homogeneity of
the resulting hybrid system is favoured. Subsequently multiple
layers of electropolymerised polydopamine were deposited to act
as a supportive and protective scaffold for the aptamer and also to
restrict the aptamer in, or near to, its preferred binding con-
formation. It was also anticipated that the polymer layer would
contribute to PSA binding by partially entrapping the protein in a
conventional surface-conﬁned imprinted cavity. It was hypothe-
sised that following PSA (template) removal, contributions to re-
binding from both the restrained aptamer and the polymer bind-
ing pocket would result in a templated hybrid surface (apta–MIP)
with PSA rebinding properties superior to aptamer alone. Elec-
trochemical impedance spectroscopy (EIS) was used to evaluate
the binding characteristics of the apta–MIP sensor for PSA and also
for a closely related protein possessing 80% sequence homology.2. Materials and methods
2.1. Instruments and reagents
Electrochemical measurements were performed using a
mAUTOLAB III/FRA2 potentiostat (Metrohm Autolab, The Nether-
lands) with a three-electrode conﬁguration comprising a Ag/AgCl
reference electrode (BASi, USA), connected via a salt bridge ﬁlled
with 10 mM phosphate buffer saline (PBS) pH 7.4 containing
150 mM NaCl and 10 mM KCl, and a platinum (Pt) counter elec-
trode (ALS, Japan). The electrochemical impedance spectrum was
measured in 10 mM PBS (pH 7.4) measurement buffer containing
10 mM ferro/ferricyanide [Fe(CN)6]3/4 in the frequency range
10 kHz to 100 mHz, with a 10 mV a.c. voltage superimposed on a
bias d.c. voltage of 0.2 V vs Ag/AgCl reference electrode (corre-
sponding to the formal potential of the redox couple). All mea-
surements were performed at room temperature.
Thiol terminated PSA binding DNA aptamer (5′-HS–(CH2)6–TTT
TTA ATT AAA GCT CGC CAT CAA ATA GCT TT-3′) was obtained from
Sigma-Aldrich, UK. PSA was obtained from Merck Chemicals Ltd.,
UK. Human glandular Kallikrein 2 (hK2) was obtained from RnD
Systems, UK. All other reagents were of analytical grade and ob-
tained from Sigma-Aldrich, UK. All aqueous solutions were pre-
pared using 18.2 MΩ cm ultra-pure water from a Milli-Q system
with a Pyrogard ﬁlter (Millipore, MA, USA).2.2. Apta–MIP preparation
Gold electrodes were cleaned and activated as detailed in the
Supporting information (Section S2). Thiolated aptamer was acti-
vated at 95° C for 10 min before being gradually cooled to room
temperature for 30 min (Savory et al., 2010). Thereafter, 1 mM ap-
tamer in TBST buffer (10 mM Tris–HCl, 10 mM KCl, 10 mM MgCl2,
0.05% Tween 20, pH 7.4)) was incubated with 1 mg/ml of PSA for
1 h at 37 °C. Clean gold electrodes were then exposed to the re-
sulting aptamer–PSA complex solution for one hour before being
rinsed carefully with ultra pure water. To saturate any free apta-
mers on the surface and favour the aptamer–PSA complex for-
mation the electrodes were subsequently incubated with 1 mg/ml
PSA for an additional 30 min before rinsing with ultrapure water
and drying under nitrogen.
The molecular imprinting step was performed by electro-
polymerising dopamine on to the aptamer–PSA modiﬁed electrode
using a method adapted from literature (Liu et al., 2006). Brieﬂy,
10 mM PBS buffer (pH 7.4) containing 5 mM dopamine was de-
gassed with nitrogen (10 min) and then electropolymerised using
cyclic voltammetry (13 cycles, 0.5 to 0.5 V vs Ag/AgCl, scan rate
of 20 mV/s). Electrodes were rinsed with water and washed (with
stirring) overnight in washing solution (5% v/v acetic acid and 5%
w/v sodium dodecyl sulphate (SDS) in water) to remove the PSA
template. Electrodes were then rinsed with water to remove re-
sidual acid and detergent before being allowed to stabilise in
measurement buffer (10 mM PBS (pH 7.4) containing 10 mM [Fe
(CN)6]3-/4- and 0.05% v/v Tween 20). A non-imprinted ‘control’
electrode (apta–NIP) was prepared in the same way but in the
absence of PSA.
2.3. Sensor performance
To evaluate sensor performance, electrodes were mounted in a
three-electrode conﬁguration with the apta–MIP or apta–NIP as
the working electrode. Following baseline stabilisation, the elec-
trodes were exposed to 100 ml of a range of PSA concentrations
(101–106 pg/ml) in measurement buffer. Electrochemical im-
pedance spectroscopy (EIS) was used to measure capacitive
changes at the electrode/electrolyte interface resulting from PSA
re-binding. Human Kallikrein 2 (hK2) was used to evaluate binding
speciﬁcity. The sensors were also challenged with varying con-
centrations of human serum albumin (HSA, prepared in the same
buffer) to study non-speciﬁc binding effects.
2.4. Microscopy
The thickness and root mean squared (RMS) roughness of
washed and unwashed apta–MIP ﬁlms on gold-coated glass slides
(Au thickness 150 nm) were determined by atomic force micro-
scopy (AFM) (Multimode Nanoscope V, Bruker, CA, USA). Prior to
analysis, both samples were rinsed with MilliQ water and dried
with a lateral ﬂow of nitrogen. Small scratches were made in each
ﬁlm using a sharp cantilever tip, o10 nm, on a rigid cantilever of
spring constant 42 N/m (NuSENSE, NuNano, Bristol, UK). Keeping
the applied force below 50 nN ensured that the scratching process
did not damage the underlying gold ﬁlm. The depth of the re-
sulting scratches was investigated at high resolution utilising a
compliant cantilever of spring constant 0.4 N/mwith a sharper tip,
o2 nm, (SCANASYST-AIR-HR, Bruker, CA, USA). The greater com-
pliance of the cantilever allows interaction forces normal to the
sample to be maintained in the region of a few hundred pN, thus
minimising possible ﬁlm compression. Images were collected at a
resolution of 2 nm/pixel.
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3.1. Fabrication of hybrid DNA aptamer–MIP surfaces
Fig. 1 provides a schematic of the fabrication technique (a–d)
and a series of voltammograms illustrating changes in the elec-
trical property of the gold electrode during the modiﬁcation pro-
cess (e). Distinct oxidation and reduction peaks of the redox cou-
ple at high current levels were observed (Fig. 1e, black line) de-
monstrating the conducting nature of the bare electrode. Follow-
ing immobilisation of the aptamer–PSA complex a reduction in
current, and a shift in peak voltage, were observed (Fig. 1e, red
line). This is attributed to the formation of a resistive aptamer–PSA
self-assembled monolayer (SAM) on the gold surface. Since im-
mobilisation of aptamer alone has been shown to produce a
densely packed surface with reduced PSA binding efﬁciency (For-
misano et al., 2015), it was hypothesised that the immobilisation of
the aptamer–PSA complex would give rise to a less densely packed
surface, due to steric hindrance provided by PSA, favouring elec-
tropolymerisation at the electrode surface and subsequent PSA
rebinding.
When preparing MIP sensor surfaces it is desirable that the
polymer layer is thin so as to enable efﬁcient transduction of
surface binding events to the underlying electrode (Panasyuk
et al., 1999). One strategy that has been successfully used to pro-
duce thin and homogenous polymer ﬁlms is the electro-
polymerisation of electroactive monomers (Blanco-López et al.,
2004). In the current study, dopamine was selected as the
monomer due to its low oxidation/reduction potential, meaning
that electropolymerisation could be performed in the presence of
the immobilised aptamer–PSA complex without fear of oxidisingFig. 1. Schematic representation of the sensor fabrication. The aptamer–PSA complex is
electropolymerisation of dopamine around the complex to produce a molecularly imprin
aptamer-lined, imprinted polymeric cavities, the so-called “apta–MIP” (c). Reintroduction
voltammetry monitoring of the fabrication process (e). (For interpretation of the referenthe thiol linkage that immobilises it on the surface (Łuczak, 2008).
In addition, it was anticipated that the hydroxyl and amide func-
tional groups of polydopamine would form non-covalent interac-
tions with PSA, thus conferring a second level of recognition acting
synergistically with the aptamer. Electropolymerisation of dopa-
mine (see Fig. S1 in Supporting information) also produced a
compact and rigid polymer that is a good insulator; a property that
is beneﬁcial for capacitive measurements (Ball et al., 2012).
An important parameter in this study was polymer thickness. If
signiﬁcantly greater than the aptamer–PSA complex height then the
on/off kinetics may be slow or even completely inhibited if the
protein becomes permanently entrapped. If the polymer layer was
much thinner than the height of the aptamer–PSA complex then
little molecular imprinting contribution would be predicted. The
number of electropolymerisation cycles was therefore varied from
7 to 25 cycles in order to identify an optimal polymer thickness.
Based on these experiments, AFM measurements and an approx-
imation of aptamer–PSA complex size, optimal polymer thickness
was predicted to be 10 nm. This polymer thickness was obtained
with 13 cycles of electropolymerisation. Aptamer–PSA template
height calculation is provided in Supporting information (Section S1).
Post polymerisation, a signiﬁcant reduction in peak current was
observed (Fig. 1e, blue curve) indicative of the presence of an in-
sulating poydopamine layer. Following washing of the imprinted
electrode, a small increase in peak current was observed
(0.6 μA) (Fig. 1e inset), however the peak current remained
signiﬁcantly lower than for the bio-functionalised gold electrodes
prior to polymerisation suggesting polymer remained on the sur-
face post-washing. It is proposed that the small increase in peak
current was not only a consequence of PSA removal but also the
loss of a small amount of loosely associated polymer. It hasﬁrst immobilised on the gold surface utilising thiol chemistry (a) with subsequent
ted surface (b). Washing of the electrode allows for removal of PSA whilst retaining
of the template molecule results in rebinding within the imprinted sites (d). Cyclic
ces to colour in this ﬁgure, the reader is referred to the web version of this article.)
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solution and it is possible that the polymer that was lost from the
electrode during the washing step was the auto-polymerised
polydopamine that had become loosely and non-speciﬁcally as-
sociated with the electrode surface (Lynge et al., 2011). A reduction
in charge transfer resistance (Rct) of approximately 50 kΩ and
20 kΩ was observed following washing of the apta–MIP and apta–
NIP respectively, again suggesting the loss of both protein and
polymer. Chronocoulometry was performed to allow estimation
aptamer density pre and post washing (see Supporting informa-
tion Section S2 and Figs. S2 and S3). No signiﬁcant changes in
aptamer density were observed post washing indicating presence
of aptamer on the electrode surface.
3.2. Physical characterisation of apta–MIP sensor
Tapping mode atomic force microscopy (AFM) was performed
in order to characterise the polymer layer. Post-polymerisation a
clear difference in wettability was observed between the apta–MIP
surface (hydrophilic) and bare-gold (hydrophobic), which re-
mained unchanged post-washing of the apta–MIP suggesting the
presence of a stable polymer layer. The root mean square (RMS)
roughness of the bare-gold surface was 2.0 nm (see Fig. S4 in
Supporting information) and this increased to 2.6 nm following
the formation of the apta–MIP (Fig. 2). Washing of the apta–MIP
with SDS and acetic acid resulted in a reduction in roughness to
2.2 nm. The thickness of the polymer layer, measured as the step-
depth between the base of a scratch and the ﬂat surface of the top
of the ﬁlm, was 10.61 nm (n¼10; SD 1.23 nm) before washing,
which decreased to 7.49 nm (n¼10; SD 0.42 nm) post washing.
This provides further evidence that washing to remove the tem-
plate (PSA) also brought about some loss of loosely associated
polymer. It should be noted that measurements were carried outFig. 2. AFM images (tapping mode) showing a planar gold surface following the formati
scratches in the polymer ﬁlm suggest a thickness of 10.6171.23 nm before washing (c)on dehydrated polymer surfaces. It is therefore likely that this is an
underestimate of their ‘in-use’ thickness given that polydopamine
has been reported to swell 1.12–1.25 times when hydrated (Ho and
Ding, 2013; Liu et al., 2015; Bernsmann et al., 2009).
3.3. Electrochemical performance of apta–MIP sensor
Electrochemical impedance spectroscopy (EIS) was used in this
study to measure capacitive changes at the electrode/electrolyte
interface as a result of PSA re-binding. Fig. 3a shows the Nyquist
plots of the system upon the addition of different PSA con-
centrations. The data can be best ﬁtted using an equivalent
circuit comprising two R||C (resistance in parallel with capacitance)
circuits in series, Rs (R1||C1) (R2||C2), where Rs is the solution re-
sistance. C2 can be replaced by a constant phase element (CPE)
with impedance ZCPE≡1/QCPE(jω)n, which accounts for a for sui-
table ﬁtting of the data. The two semicircles are likely to be as-
sociated with the electrochemical double layer and with the
polymer itself. For the blank measurement of the sample shown in
Fig. 3a and b with a 1.0 mm radius, the ﬁtted values are
R1¼0.419 kΩ cm2, R2¼11.0 kΩ cm2, C1¼86.9 mF cm2, QCPE¼
4.00 mF sn1cm2 and n¼0.774, which corresponds to an esti-
mated capacitance value of C2¼0.620 mF cm2 by using the con-
version C2¼(R2QCPE)1/n/R2 (Hsu and Mansfeld, 2001).
The high values of charge transfer resistance observed for the
system, are compatible with the presence of the insulating poly-
mer and the electrical potential barrier created by the negative
charge of the aptamers towards the negatively charged redox
markers in solution. As PSA binds to the cavities of the apta–MIP,
less DNA charge is exposed to the outer electrolyte, causing a re-
duction in the resistance of the system. The screening of the
charge of the PSA-speciﬁc DNA aptamer has previously been re-
ported in the literature (Jolly et al., 2015b).on of the apta–MIP layer before (a) and after (b) washing. Analysis of proﬁles across
, which decreases to 7.4970.42 nm following washing (d).
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Fig. 3. Impedance Nyquist (a) and capacitance Cole–Cole (b) plots of the apta–MIP sensor incubated with different concentration of PSA. The lines in the Nyquist plot
represent the ﬁttings of the data with the equivalent circuit described. Impedance Nyquist (c) and capacitance Cole-Cole (b) plots of apta–NIP sensor incubated with different
concentration of PSA.
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luation of the capacitance of the system can be obtained by de-
ﬁning a complex capacitance
C C jC
j Z
Z
Z
j
Z
Z
1
12 2ω ω ω
* = ′ + ″ ≡ = − ″ − ′
( )
Fig. 3b shows the Cole–Cole capacitance plots at higher fre-
quencies before and after PSA binding events; measurable changes
in the capacitance are observed upon PSA interaction. The
screening of the aptamer charges coupled with the ﬁlling of the
polymer cavities could further explain the increase in capacitance
of the system as PSA binds to the apta–MIP sensor. These changes
were negligible in the apta–NIP sensor as shown in Fig. 3c and d
demonstrating little PSA interaction with the control sensor sur-
face (for full frequency range plots, before and after PSA binding to
MIP and NIP, see Supporting information Section S4 and Figs. S5
and S6).
Due to the high impedance values of the system and the rela-
tively low exponent n of the CPE, estimation of the capacitance ofthe system through ﬁtting of the data with an equivalent circuit
yields large errors. The errors are then exacerbated by the calcu-
lation of the capacitance through the ﬁtted values of the constant
phase element. Therefore we have used as our signal the measured
impedance at a ﬁxed frequency (1 Hz) so that the evolution of the
signal can be monitored without the need for ﬁtting. The capaci-
tance, calculated as C¼1/jωZ″ at 1 Hz, for dose response with
the apta–MIP and the apta–NIP sensor is shown in Fig. 4. Capaci-
tance variations were obtained with respect to the baseline signal
after achieving stability. The apta–MIP sensor incubated with
0.1 pg/ml PSA showed a capacitance change of 5% while 1 mg/ml
PSA gave rise to a signal change of 47% demonstrating high
sensitivity in terms of sensor response. To put this result in to
perspective, a closely analogous ‘aptamer only’ PSA sensor, also
developed by our group using the same DNA aptamer (Jolly et al.,
2015b), was shown to have a limit of detection of 1 ng/mL with a
signal change 3%. This suggests that the imprinting step resulted
in an impressive increase in sensivity of around three orders of
magnitude. The apta–MIP sensor showed a linear response from
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legend, the reader is referred to the web version of this article.)
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compasses the clinical range of PSA concentration used for PCa
detection (4–10 ng/ml) (Heidenreich et al., 2014a). Control poly-
mers, so-called apta–NIPs, were prepared in the same way but in
the absence of PSA. The apta–NIPs showed a decrease in capaci-
tance of up to 6% when incubated with 1 mg/ml PSA (Fig. 4, green
data points). This is likely due to a small amount of non-speciﬁc
interaction between PSA and the polydopamine ﬁlm leading to an
increase in the resistance to the ﬂow of redox ions to the sensor
surface. This large difference in the behaviour of the apta–NIP as
compared to the apta–MIP is interesting; it strongly suggests that
the binding of PSA to the aptamer prior to polymerisation some-
how ‘protects’ the aptamer PSA binding site from ‘denaturation’
during polymer growth. To further explore our hybrid-MIP hy-
pothesis an experiment was performed to evaluate the effect of
the wash-step on the functioning of the apta–MIP. In the absence
of acetic acid and SDS in the wash solution, it was proposed that
template PSA would remain bound to the apta–MIP and would
effectively prevent binding of additional PSA and this is exactly
what was observed. Fig. 4 clearly shows (blue dots) that in the
absence of acetic acid and SDS in the wash-step (template re-
moval) the apta–MIP surface did not respond to PSA upon re-
incubation. This strongly supports our hypothesis that reversible
PSA binding or ‘templating’ protects the aptamer during poly-
merisation. This control study also eliminates the possibility that1x104 1x106
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Fig. 5. Selectivity study of the apta–MIP with different concentrations of hK2 (a, blue) a
references to colour in this ﬁgure legend, the reader is referred to the web version of tbinding of PSA to the apta–MIP surface is a result of ‘protein–
protein’ (PSA–PSA) binding. It is likely that the very weak response
of the apta–NIP surface to PSA is due to the aptamer being ‘over-
grown’ during polymerisation. It is probable that in the absence of
a PSA template aptamer molecules pack more closely, and favour
conformations that lie more closely to the gold surface when
surface immobilised and as such become more vulnerable to
polymer entrapment.
3.4. Evaluation of the selectivity of the apta–MIP
In order to evaluate the ability of the apta–MIP sensor to dis-
criminate between PSA and other related proteins, the system was
non-competitively challenged with human Kallikrein 2 protein
(hK2). hK2 is a member of the same kallikrein family as PSA and is
80% homologous (Hong, 2014). Most antibodies raised against PSA
exhibit cross-reactivity with hk2 due to similar epitopic regions
and although the concentration of hK2 is 100 fold lower than PSA
in clinical samples, this protein served as stringent control to
evaluate apta–MIP selectivity (Väisänen et al., 2006). Upon in-
cubation with increasing concentrations of hK2, the apta–MIP
sensor exhibited a much reduced response as compared to PSA;
approximately 10% (hK2) compared to 42% (PSA) signal change
when incubated with 100 ng/ml of the respective proteins
(Fig. 5a). (For the response of the apta–MIP sensor over the entire
range of hK2 concentrations see Fig. S7 in Supporting informa-
tion). The ‘aptamer only’ sensor gave a signal change of 1.6% with
hK2 at 100 ng/ml while a signal change of 32% was observed with
PSA (Jolly et al., 2015b). This suggests that PSA/hK2 aptamer se-
lectivity has been to a degree lost in the imprinting step. An ex-
planation for this might be that the aptamer relies on a small
number of very speciﬁc and differentiating interactions between
loci on the DNA and protein in order to discriminate between PSA
and hK2. When the polymer layer builds it initially ‘captures’ the
lower part of the aptamer–PSA complex. Given the assumption
that the protein–aptamer complex is orientated so that the apta-
mer is closer to the electrode surface than the protein, the growing
polymer layer builds around aptamer ﬁrst, then the area of inter-
action between aptamer and protein and ﬁnally around the pro-
tein so that the polymer surrounds the parts of the protein that are
furthest from the electrode surface. Given the homology between
the two proteins and the generality of the non-covalent interac-
tions established between polymer and protein it is not surprising
that a large number of non-covalent interactions would not only
result in increased afﬁnity but also lead to reduced selectivity. The
selectivity of the apta–MIP sensor could possibly be further im-
proved by using electroactive monomers that display a higher1x105 1x106 6.7x108 6.7x109
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lored” to PSA. It might also be possible to carefully control the
thickness of the polymer layer to achieve a balance between
polymer–protein and aptamer–protein interactions. When the
apta–NIPs were challenged with hK2 (100 ng/ml), a signal change
of 1.5% was observed which was lower than the PSA response of
5%. The net charge of hK2 is negative, whereas at neutral pH the
net charge of PSA is positive and this difference in charge is likely
responsible for the difference in non-speciﬁc binding observed
(Villoutreix et al., 1994). In the clinical setting, given the large
difference in concentrations of the two proteins in the blood,
signiﬁcant interference from hK2 is unlikely (Väisänen et al.,
2006).
Although the usefulness of PSA as a means to diagnose prostate
cancer is questionable, it is important that any sensor developed
for use within a clinical setting retains sensitivity when challenged
with biological samples. The sensor was challenged with various
concentrations of human serum albumin (HSA), the main plasma
protein, in order to investigate potential fouling issues. HSA at
0.1 mg/ml and 1 mg/ml showed signal changes of 3% and 5% re-
spectively (Fig. 5b). HSA is a negatively charged protein at pH 7.4
(Fogh-Andersen et al., 1993), which could lead to electrostatic
repulsion between the polymer DNA layer and the protein re-
sulting in low signal change. A maximum capacitive change of 11%
was observed when the sensor was challenged with HSA at a
concentration of 6.7 mg/ml (physiological range 3.5–5 mg/mL),
which may result from a combination of non-speciﬁc interaction
with polydopamine as well as protein–protein interactions. HSA
interaction with apta–NIPs was similar to PSA interaction with
apta–NIPs, showing negligible change at lower concentrations and
an increase in capacitance with a signal change of 3.5% at 6.7 mg/
ml HSA. These studies are encouraging, however, validation with
clinical samples would be required to demonstrate true clinical
utility.
This brings the discussion to the key point: ‘is this evidence of a
molecular imprinting effect?’. The mechanism underpinning the
proposed hybrid MIP approach requires that the aptamer is re-
strained in a ‘binding’ conformation to deliver improvements in
binding efﬁciency by thermodynamically favouring PSA binding to
a conformationally restrained aptamer. It is hypothesised that
improved afﬁnity, and potentially selectivity, is a consequence of
the aptamer and the polymer (MIP) acting synergistically. It is
proposed that the polymer growth around the aptamer–PSA
complex results in the aptamer being held in, or close to, its
binding conformation following PSA removal. This restriction in
free-movement of the aptamer reduces the entropy of the ‘un-
bound’ receptor favours rebinding by reducing the loss in entropy
that would occur when PSA binds. There is also an argument for a
reduction in enthalpy since there would be fewer non-covalent
interactions between aptamer and polymer than would exist for
the fully solvated form of the aptamer. In addition, it is reasonable
that any reduction in aptamer solvation would also contribute to a
reduction in PSA binding entropy loss. For this to happen template
removal and subsequent re-binding must not be hampered by
polymer-induced conformational restriction of the aptamer; there
being an underlying assumption that binding-induced conforma-
tion changes, and the permanent capture of this conformation
within a polymer support, does not result in permanent entrap-
ment of the ‘PSA’ template. Fig. 4 suggests this is not the case since
the ability to turn the afﬁnity of the apta–MIP ‘on’ and ‘off’ by
varying wash conditions is best explained in terms of the wash’s
ability to bring about template removal. This entrapment process
itself could reasonably be described as ‘imprinting’ since the ap-
tamer–PSA complex is effectively ‘imprinted’ within the poly-
dopamine layer; even in the absence of any association between
the PSA ‘template’ and the polymer. The proposed hybrid-MIPmechanism also requires that the polymer contributes to binding,
in a typical non-covalent imprinting manner, by directly inter-
acting with the template. Whether this happens to any great ex-
tent depends on the relative sizes of the aptamer and template and
importantly on the thickness of the polymer layer. For instance if
the template is a low molecular weight molecule, little interaction
with the polymer might be expected as the aptamer when bound,
effectively forms a shield around the molecule. If on the other
hand the template is a similar or larger than the aptamer, then
signiﬁcant polymer interaction might be envisaged giving rise to
an enhanced ‘conventional’ non-covalent imprinting effect. The
polymer thickness also plays a critical role in the formation of the
hybrid imprinted site and in this case, given the polymer thickness
is roughly the size of the aptamer PSA template (9–10 nm) and
that the 3D structure of PSA is larger than that of the aptamer, it is
not unreasonable to assume that there would be signiﬁcant direct
interaction between the polymer and PSA.
So does the data demonstrate an imprinting effect? The data in
Fig. 4 clearly shows that the apta–MIP has excellent sensitivity for
PSA with a detection limit between 1 and 10 pg/ml, yet whilst this
illustrates efﬁcacy it is not direct evidence for an imprinting effect.
The clearest evidence for a signiﬁcant imprinting effect comes
from the comparison with then previously published study (Jolly
et al., 2015b) with the key observation being the large difference it
the PSA limit of detection for the two systems. Whilst differences
in aptamer surface-density and orientation would undoubtedly
play some role in accounting for differences in performance it is
very unlikely that at concentrations, for both systems, well below
any observable saturation this could account for the difference
observed. We therefore conclude that this improvement in the
limit of detection for apta–MIP is the result of an imprinting
contribution to the afﬁnity of the system. Although it is clear that
an imprinting effect has signiﬁcantly improved the performance of
the apta–MIP sensor compared to the aptasensor, it remains un-
clear as to whether this is the result of the conformational re-
striction of the aptamer, the establishment of non-covalent inter-
actions between polymer and PSA or some combination of both.4. Conclusions
By combining conventional bio-recognition motifs with mole-
cular imprinting, a highly sensitive hybrid sensor has been gen-
erated. Using controlled electropolymerisation to bring about
capture of the aptamer–PSA complex a three fold increase in
sensitivity over a conventional aptasensor has been demonstrated,
which is hypothesised to be a consequence of synergistic re-
cognition of PSA by both the aptamer and the imprinted cavity.
The sensor displayed good selectivity when challenged with a
homologous protein hK2 and additionally good resistance to
fouling from serum protein HSA. This strategy could be extended
to various diagnostically relevant proteins using not only aptamers
but also other afﬁnity molecules such as peptides, afﬁrmers and
antibody fragments.Acknowledgements
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